Skip to content
IRIS episode artwork

Feb 14, 2019 15 min

IRIS

from OncoPharm Hosted by John Bossaer

The Landmarks in Oncology Pharmacy series returns to discuss the International Randomized Study of Interferon vs. STI571 (imatinib) aka IRIS.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

IRIS

0:00 15:50

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 15 minutes long.

When was this OncoPharm episode published?

This episode was published on February 14, 2019.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.